![$RAC announces conclusion of an investigator-sponsored trial of bisantrene – Race Oncology](https://oncodaily.com/pub/uploads/2024/08/GTtIwXbb0AAuF8q-e1722555373254.jpeg)
Photo taken from Race Oncology/X
Aug 2, 2024, 00:52
$RAC announces conclusion of an investigator-sponsored trial of bisantrene – Race Oncology
Race Oncology made the following post on X:
“$RAC is pleased to announce the successful conclusion of an investigator-sponsored Phase 1b/2 trial of bisantrene, with trial results showing the drug, in combination with clofarabine and fludarabine, has achieved its primary endpoint for efficacy.
More.”
Source: Race Oncology/X